Neoadjuvant Dual Checkpo intInhibitors vs Anti-PD1 Therapy in High-Risk Resectable Melanoma: A Pooled Analysis(vol 10, pg 612, 2024)

被引：0
|
作者：
Mangla, A.
Lee, C.
Mirsky, M. M.
机构：
来源：
JAMA ONCOLOGY | 2024年 / 10卷 / 08期
关键词：
D O I：
10.1001/jamaoncol.2024.3182
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1138 / 1138
页数：1
相关论文
共 23 条
  • [1] Neoadjuvant Dual Checkpoint Inhibitors vs Anti-PD1 Therapy in High-Risk Resectable Melanoma
    Mangla, Ankit
    Lee, Chanmi
    Mirsky, Matthew M.
    Wang, Margaret
    Rothermel, Luke D.
    Hoehn, Richard
    Bordeaux, Jeremy S.
    Carrol, Bryan T.
    Theuner, Jason
    Li, Shawn
    Fu, Pingfu
    Kirkwood, John M.
    JAMA ONCOLOGY, 2024, 10 (05) : 612 - 620
  • [2] Clinical outcomes after adjuvant anti-PD1 therapy for high-risk resectable melanoma and predictors of response
    Marsiglio, John
    Bingjian, Feng
    Kovacsovics, Magdalena
    Gibson, Berit
    Zhou, Qin
    Swami, Umang
    Russell, Jeffery Scott
    Erickson-Wayman, Alyssa
    Asare, Elliot Amponsah
    Monroe, Marcus
    Bowles, Tawnya Lynn
    Nix, David
    Williams, Matthew
    Tan, Aik-choon
    Hyngstrom, John Robert
    Hu-Lieskovan, Siwen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma (vol 24, pg 1649, 2018)
    Amaria, Rodabe N.
    Reddy, Sangeetha M.
    Tawbi, Hussein A.
    Davies, Michael A.
    Ross, Merrick I.
    Glitza, Isabella C.
    Cormier, Janice N.
    Lewis, Carol
    Hwu, Wen-Jen
    Hanna, Ehab
    Diab, Adi
    Wong, Michael K.
    Royal, Richard
    Gross, Neil
    Weber, Randal
    Lai, Stephen Y.
    Ehlers, Richard
    Blando, Jorge
    Milton, Denai R.
    Woodman, Scott
    Kageyama, Robin
    Wells, Daniel K.
    Hwu, Patrick
    Patel, Sapna P.
    Lucci, Anthony
    Hessel, Amy
    Lee, Jeffrey E.
    Gershenwald, Jeffrey
    Simpson, Lauren
    Burton, Elizabeth M.
    Posada, Liberty
    Haydu, Lauren
    Wang, Linghua
    Zhang, Shaojun
    Lazar, Alexander J.
    Hudgens, Courtney W.
    Gopalakrishnan, Vancheswaran
    Reuben, Alexandre
    Andrews, Miles C.
    Spencer, Christine N.
    Prieto, Victor
    Sharma, Padmanee
    Allison, James
    Tetzlaff, Michael T.
    Wargo, Jennifer A.
    NATURE MEDICINE, 2018, 24 (12) : 1942 - 1942
  • [4] Safety and efficacy of adjuvant anti-PD1 therapy (nivolumab) in combination with vaccine in resected high-risk metastatic melanoma
    Gibney, Geoffrey Thomas
    Weber, Jeffrey S.
    Kudchadkar, Ragini Reiney
    De Conti, Ronald C.
    Tetteh, Leticia
    Eysmans, Cabell
    Yu, Bin
    Martinez, Alberto J.
    Younos, Ibrahim
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Real-Life Cohort of Patients With Resected High-Risk Melanoma Treated by Adjuvant Anti-PD1 Therapy
    Benzoni, Liza
    Eberhardt, Anais
    Milley, Sarah
    Idoudi, Safa
    Trefcon, Camille
    Romain-Scelle, Nicolas
    Thomas, Luc
    Dalle, Stephane
    CANCER MEDICINE, 2025, 14 (06):
  • [6] Neotrio trial - optimal neoadjuvant sequencing of anti-PD1 and BRAF targeting therapy in resectable BRAF mutant stage IIIB/C/D melanoma: results of histopathological analysis
    Braden, J.
    Potter, A.
    Paver, E.
    Rawson, R.
    Menzies, A.
    Carlino, M.
    Au-Yeung, G.
    Saw, R.
    Spillane, A.
    Stretch, J.
    Shannon, K.
    Pennington, T.
    Ch'ng, S.
    Gyorki, D.
    Howle, J.
    Daneshvar, D.
    Wilmott, J.
    Lo, S.
    Silva, I.
    Scolyer, R.
    Long, G.
    HISTOPATHOLOGY, 2022, 81 : 50 - 51
  • [7] NeoTrio trial: Optimal neoadjuvant sequencing of anti-PD1 and BRAF targeting therapy in resectable BRAF mutant stage IIIB/C/D melanoma: Results of translational investigations
    Braden, Jorja
    Potter, Alison J.
    Paver, Elizabeth
    Menzies, Alexander M.
    Carlino, Matteo S.
    Au-Yeung, George
    Saw, Robyn P.
    Spillane, Andrew J.
    Stretch, Jonathan R.
    Shannon, Kerwin F.
    Pennington, Thomas E.
    Ch'ng, Sydney
    Gyorki, David
    Howle, Julie
    Deneshvar, Dariush
    Silva, Ines P.
    Scolyer, Richard A.
    Wilmott, James S.
    Long, Georgina V.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 163 - 163
  • [8] Chemotherapy in combination with anti-PD-1 agents as adjuvant therapy for high-risk oral mucosal melanoma
    Yunteng Wu
    Dongliang Wei
    Guoxin Ren
    Wei Guo
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2293 - 2300
  • [9] Chemotherapy in combination with anti-PD-1 agents as adjuvant therapy for high-risk oral mucosal melanoma
    Wu, Yunteng
    Wei, Dongliang
    Ren, Guoxin
    Guo, Wei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2293 - 2300
  • [10] Anti-PD1-based neoadjuvant therapy in resectable stage III or IV melanoma patients: A systematic review and meta-analysis
    Madeira, T. M.
    Moraes, F. Cezar A.
    Priantti, J. N.
    Santiago, E. Moises de Lima
    Ribeiro, M. F.
    Vilbert, M. Silveira
    ANNALS OF ONCOLOGY, 2023, 34 : S661 - S661
123